Table 3.
Variable | OR (95% CI) |
---|---|
Age, years | |
50–59 vs. <50 | 0.88 (0.56–1.38) |
60–69 vs. <50 | 1.12 (0.73–1.71) |
70–79 vs. <50 | 1.25 (0.80–1.95) |
≥80 vs. <50 | 1.06 (0.66–1.70) |
Race | |
African American vs. Caucasian | 1.64 (1.07–2.50) |
Other vs. Caucasian | 1.22 (0.69–2.16) |
Comorbidity | |
1 comorbidity vs. 0 | 1.27 (0.95–1.70) |
2 comorbidities vs. 0 | 1.42 (1.06–1.91) |
3 comorbidities vs. 0 | 1.56 (1.17–2.07) |
Complications | |
1 complication vs. no complications | 1.02 (0.84–1.23) |
2 complications vs. no complications | 1.11 (0.86–1.44) |
≥3 complications vs. no complications | 0.90 (0.65–1.24) |
LOS category, days | |
LOS 6–8 vs. LOS 0–5 | 0.92 (0.62–1.34) |
LOS 9–11 vs. LOS 0–5 | 0.81 (0.55–1.21) |
LOS 12–14 vs. LOS 0–5 | 0.71 (0.46–1.11) |
LOS ≥15 vs. LOS 0–5 | 0.43 (0.27–0.67) |
Neobladder | |
Neobladder vs. no neobladder | 1.45 (1.09–1.93) |
Hospital volume (no. cystectomies) | |
10–49 vs. <10 | 1.04 (0.83–1.30) |
≥50 vs. <10 | 1.10 (0.81–1.51) |
Hospital type | |
Academic vs. non-academic | 1.00 (0.78–1.28) |
Disposition | |
Home healthcare vs. routine home | 1.04 (0.87–1.26) |
Post-acute care facility vs. routine home | 3.79 (2.88–4.98) |
OR: odds ratio; CI: confidence interval; LOS: length of stay.